Freshworks Shorts Rebuild as Earnings Loom
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
FRSH gained just 0.3% over the past week, lagging a peer median of 2.1%, with short interest climbing 23% over the past month even as the stock recovered from October lows.
Short sellers have been rebuilding aggressively. Short interest now stands at 11.5% of the free float, up from roughly 8.5% a month ago. Most of that increase landed in the week of October 8 to 12, when short shares jumped from around 22 million to nearly 29 million in a matter of days. The borrow market remains loose despite the build: availability is running at 815%, meaning there are more than eight times as many shares available to lend as are currently out on loan. Cost to borrow is just 0.49%, up 14% on the week but still near the low end of its 30-day range. Shorts have taken on meaningful exposure without paying up for it. Options tell a slightly more defensive story. The put/call ratio is 0.12, above its 20-day average of 0.10 by about 1.3 standard deviations. That is not extreme, but it is the highest the ratio has been since late September, suggesting some investors are hedging into next week's print rather than positioning outright short.
The Street picture is broadly constructive but fragmented. The consensus is Buy across seven analysts, with a mean price target of around $14.79, close to where the stock is trading at $14.90. Keybanc initiated coverage in mid-September at Overweight with an $18 target, and both UBS and Cantor Fitzgerald lifted their targets after the August earnings print. Piper Sandler sits at Neutral with a $12 target, reflecting concern about the pace of the CX business. The bull case rests on the employee experience segment, which was growing at 26% year-on-year, and on free cash flow margins above 25%. The bear case points to the CX unit, which accounts for roughly 45% of revenue and decelerated to 5% constant-currency growth. Customer numbers also dropped by around 400 in the most recent quarter. On valuation, the EV/EBITDA multiple has drifted down slightly over the past 30 days, while the P/E has risen to just under 19x as the share price recovered. Factor scores are mixed: EPS momentum ranks in the 63rd percentile on a 30-day basis and 72nd on 90 days, but EPS surprise ranks only in the 21st percentile, and the forward earnings growth score is a weak 9.
Retail attention has jumped sharply. The Wikipedia and ORTEX page-view signal, which measures attention against the company's own 90-day history, registered a z-score of 5.0 as of October 19. That places current interest well outside normal bounds. The company's next earnings report is scheduled for November 3, and the uptick in Wikipedia traffic is consistent with individual investors researching the name ahead of that date. The signal is flagged as an attention measure rather than a revenue indicator.
Among the top holders, BlackRock added 2.6 million shares in the quarter to September 30, lifting its stake to 7.5% of shares outstanding. AQR added over 6 million shares through to June 30. Haveli Investment Management built a position of 8.2 million shares from scratch in the same quarter. On the activist register, Peak XV Partners and Douglas Leone both filed Schedule 13D disclosures, indicating activist intent. Peak XV's most recent filing showed a stake of around 4.0%, down from 4.1%, as of February 2025. These are disclosed positions around the 5% threshold and may have changed since the filings without triggering a further disclosure. Insider activity has been limited to compensation-related transactions. The CEO, CFO and CRO all had tax-withholding sales on October 2, which are mechanics of share-vesting rather than open-market selling. Net insider flow over the past 90 days is marginally negative at just under 56,000 shares.
The earnings history on record shows the stock fell 2.1% the day after the August 2026 print, then recovered 1.7% over the following week. The prior comparable event in late July 2026 produced a one-day gain of 7.3% and a five-day gain of 11.3%. With the next print six days away, the key question is whether the CX segment has stabilised or continued to slow, and whether the short interest that rebuilt rapidly through October will face pressure if the EX unit sustains its growth rate.
Stocks in this article
See the live data behind this article on ORTEX.
Open FRSH on ORTEX →How this article was generated
- Generated
- 28 Oct 2026, 20:48
- Data as of
- 28 Oct 2026, 20:48
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.